secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001193125-25-138802
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics suspends ATM prospectus; Sales Agreement remains in effect
-------------------------------------------------------------------------------

- Delivered notice to Jefferies to terminate ATM prospectus dated Feb 6, 2025.
- No sales of common stock under Sales Agreement until new prospectus filed.
- Underlying Open Market Sale Agreement with Jefferies remains in full force.
- Company retains ability to resume ATM sales after filing new prospectus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525138802/0001193125-25-138802-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525138802/d779986d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-138802

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer